# SRPX2 exhibits neuroprotective effects in neural stem cells: inhibition of OGD/R-stimulated apoptosis and oxidative stress

**Authors:** Pan Li, Jie Hua

PMC · DOI: 10.1515/biol-2025-1182 · Open Life Sciences · 2026-01-13

## TL;DR

This study shows that SRPX2 protects neural stem cells from damage caused by hypoxic-ischemic encephalopathy by reducing cell death and oxidative stress.

## Contribution

The novel finding is that SRPX2 exerts neuroprotective effects by activating the Wnt/β-catenin pathway in hypoxic-ischemic conditions.

## Key findings

- SRPX2 improves survival of OGD/R-stimulated neural stem cells.
- SRPX2 inhibits apoptosis and oxidative stress in OGD/R-stimulated NSCs.
- SRPX2 activates the Wnt/β-catenin pathway to suppress apoptosis and oxidative stress.

## Abstract

Hypoxic-ischemic encephalopathy (HIE) is a major cause of infant morbidity as well as mortality. Neural stem cells (NSCs) is essential for brain development and function, and the role of NSCs in HIE is crucial and deserves further study. Sushi repeat-containing protein X-linked 2 (SRPX2) is a novel chondroitin sulfate proteoglycan which has multiple biological functions, such as cell growth and adhesion. However, SRPX2 is rarely reported in HIE process, and the mechanism is unclear. Herein, we aimed to uncover the role of SRPX2 in the progression of HIE. The oxygen-glucose deprivation/reoxygenation (OGD/R) model was established as a HIE cell model. We revealed that SRPX2 improves survival of OGD/R-stimulated NSCs. SRPX2 inhibited apoptosis of OGD/R-stimulated NSCs. Further data confirmed SRPX2 restrained oxidative stress of OGD/R-stimulated NSCs. Mechanically, SRPX2 activated the Wnt/beta-catenin pathway, and therefore suppressed the apoptosis as well as oxidative stress of OGD/R-stimulated NSCs. Collectively, SRPX2 suppressed apoptosis as well as oxidative stress of OGD/R-stimulated NSCs by activating Wnt/β-Catenin pathway.

## Linked entities

- **Genes:** SRPX2 (sushi repeat containing protein X-linked 2) [NCBI Gene 27286]
- **Diseases:** hypoxic-ischemic encephalopathy (MONDO:0006663), HIE (MONDO:0006663)

## Full-text entities

- **Genes:** EGF (epidermal growth factor) [NCBI Gene 403657] {aka CEGF}, Sox2 (SRY-box transcription factor 2) [NCBI Gene 499593] {aka RGD1565646}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], FGF2 (fibroblast growth factor 2) [NCBI Gene 403857] {aka BFGF}, Ccnd1 (cyclin D1) [NCBI Gene 58919], Ctnnb1 (catenin beta 1) [NCBI Gene 84353] {aka Catnb}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 84027], Srpx2 (sushi-repeat-containing protein, X-linked 2) [NCBI Gene 317181] {aka RGD1562444}, Mpo (myeloperoxidase) [NCBI Gene 303413], Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, SRPX2 (sushi repeat containing protein X-linked 2) [NCBI Gene 27286] {aka BPP, CBPS, PMGX, RESDX, SRPUL}, Casp3 (caspase 3) [NCBI Gene 25402] {aka CPP32-beta, Lice, Yama}, Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Wnt2 (Wnt family member 2) [NCBI Gene 114487] {aka Wnt}, Hist1h3b (histone cluster 1, H3b) [NCBI Gene 680498], Anxa5 (annexin A5) [NCBI Gene 25673] {aka Anx5, CPB-I, LC5}, Myc (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 24577] {aka RNCMYC, c-myc, mMyc}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, SRPX2 [NCBI Gene 492014], Cdh1 (cadherin 1) [NCBI Gene 83502], Wnt3a (Wnt family member 3A) [NCBI Gene 303181], Actb (actin, beta) [NCBI Gene 81822] {aka Actx}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}
- **Diseases:** hypoxic (MESH:D002534), stroke (MESH:D020521), neurological disorders (MESH:D009461), ischemia (MESH:D007511), seizures (MESH:D012640), hypoxia (MESH:D000860), NSC (MESH:D000092423), non-small cell lung cancer (MESH:D002289), injury (MESH:D014947), inflammatory (MESH:D007249), pancreatic cancer (MESH:D010190), craniocerebral injury (MESH:D006259), brain tissue ischemia (MESH:D002545), Alzheimer's disease (MESH:D000544), TBI (MESH:D000070642), infarct (MESH:D007238), neuronal damage (MESH:D009410), speech loss (MESH:D013064), amyloid (MESH:C000718787), esophageal cancer (MESH:D004938), necrosis (MESH:D009336), HIE (MESH:D020925), nervous system diseases (MESH:D009422), tissue injury (MESH:D017695), birth defects (MESH:D000014), hypothermia (MESH:D007035), colon cancer (MESH:D015179), brain damage (MESH:D001925), MCAO (MESH:D020244), brain lesion (MESH:D001927), brain injury (MESH:D001930), life disorders (MESH:D003643), ischemic injury (MESH:D017202), ischemic stroke (MESH:D002544), R (MESH:C580424), OGD (MESH:C536050), ischemic cerebrovascular diseases (MESH:D002561)
- **Chemicals:** atropine (MESH:D001285), Edaravone (MESH:D000077553), SDS (MESH:D012967), HCl (MESH:D006851), resveratrol (MESH:D000077185), chondroitin sulfate (MESH:D002809), sodium deoxycholate (MESH:D003840), NaCl (MESH:D012965), O2 (MESH:D010100), PI (MESH:D010716), N (MESH:D009584), NP-40 (MESH:C010615), epinephrine (MESH:D004837), Triton X-100 (MESH:D017830), CO2 (MESH:D002245), paraformaldehyde (MESH:C003043), PVDF (MESH:C024865), PBS (MESH:D007854), ROS (MESH:D017382), Glucose (MESH:D005947), DMSO (MESH:D004121), DAPI (MESH:C007293), melatonin (MESH:D008550), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), Alexa Fluor 594 (-), DCF (MESH:D015649), MTT (MESH:C070243), MDA (MESH:D008315), Alexa Fluor 488 (MESH:C000711379)
- **Species:** Moloney murine leukemia virus (no rank) [taxon 11801], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** NSC — Homo sapiens (Human), Transformed cell line (CVCL_B6QU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917582/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917582/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917582/full.md

---
Source: https://tomesphere.com/paper/PMC12917582